Quest Diagnostics (DGX) PT Raised to $104.50 at Evercore ISI
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Quest Diagnostics (DGX) PT Raised to $115 at Canaccord Genuity Following Strong 1Q Report; 'Continues to Prove Skeptics Wrong... Q1 was a Blowout'
April 24, 2017 9:35 AM EDTCanaccord Genuity raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $102.00) while maintaining a Buy rating, following the company's first quarter report.
Analyst Mark Massaro notes the company provided one of its best earnings reports in 4 years, delivering first quarter... More
Quest Diagnostics (DGX) PT Raised to $115 at UBS; 'Improved Growth Profile Continues to Build Confidence'
April 24, 2017 9:14 AM EDTUBS raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $102.00) while maintaining a Buy rating, following a company update post first quarter results.
Analyst A.J. Rice notes management's strong execution of growth opportunities such as hospital deals that could... More
Quest Diagnostics (DGX) PT Raised to $115 at Deutsche Bank
April 21, 2017 8:26 AM EDTDeutsche Bank raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $108.00) while maintaining a Buy rating.
... MoreQuest Diagnostics (DGX) Tops Q1 EPS by 15c; Raises FY17 EPS Outlook
April 20, 2017 6:47 AM EDTQuest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.33, $0.15 better than the analyst estimate of $1.18. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.87 billion.
"We delivered strong growth across the board in the first quarter with gains in revenues,... More
